Through
its research and development efforts in Israel, Cannabics Pharmaceuticals is
focused on developing a wide and deep pipeline of advanced cannabinoid based
therapies. As an integral part to its efforts at building shareholder value,
CNBX is committed to working with major medical centers in Israel while
exploring the beneficial effects of its products in diverse indications.
The
company’s core product is Cannabics SR, which is best defined as a sustained
release medical cannabis capsule designed for cancer patients as a palliative
care treatment. The company’s proprietary SR technology provides ten to twelve
hours of steady-state, beneficial therapeutic effects and, as a result, allows
for a convenient oral, once-per-day dosing regimen for patients.
Most
notably, CNBX is in preparation to launch its line of SR products in eligible
US states and EU markets under existing medical cannabis regulatory policies.
The company now finds itself in the final stages of planning a series of formal
clinical studies that are anticipated to show the medical benefits of its
products aimed at patients suffering from a variety of ailments.
Earlier
this month, the company confirmed that it had executed an IP Licensing and
Collaboration Agreement with Kalapa Holding, a leading medical cannabis
provider and distributor in Spain. Kalapa’s offerings include a wide variety of
medical cannabinoid based products. The agreement with Kalapa will provide
momentum in the production and distribution of Cannabics SR products within the
Spanish market.
In strict
compliance with Spanish laws and regulations, Cannabics SR medical cannabis
products will be available to certified patients only through a regulated
Spanish entity and affiliate of Kalapa Holding, the Asociacion Centro Cannabico
de Terapias Naturales. The products will be locally manufactured from pure
extracts produced from high quality, organic medical cannabis strains by
Kalapa’s affiliate, KSK Labs.
Cannabics
Pharmaceuticals is focused on developing and marketing sophisticated drugs,
therapies, food supplements and administration routes based on the active
ingredients found in unique strains of the cannabis plant.
For more
information, visit www.cannabics.com
About QualityStocks
QualityStocks
is committed to connecting subscribers with companies that have huge potential
to succeed in the short and long-term future. We offer several ways for
investors to find, evaluate, and learn more about investing in these companies.
Sign up
for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The
Quality Stocks Daily Blog http://blog.qualitystocks.net
The
Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The
Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
No comments:
Post a Comment